Tango Therapeutics Inc (TNGX) — Cash Flow Quality Index
Latest as of September 2025:
-1.95x
Tango Therapeutics Inc (TNGX) has a Cash Flow Quality Index of -1.95x as of September 2025. Operating cash flow of $-30.95 Million is below net income of $15.88 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore how large is Tango Therapeutics Inc's balance sheet for the complete picture of this company's asset base.
Cash Flow Quality Index
-1.95x
Operating CF / Net Income
Operating Cash Flow
$-30.95 Million
USD
Net Income
$15.88 Million
USD
Data as of
Sep 2025
Most recent filing
Annual Cash Flow Quality Index for Tango Therapeutics Inc (None–None)
Year-by-year earnings quality comparison for Tango Therapeutics Inc. For live market cap and the full company financial profile, see Tango Therapeutics Inc (TNGX) total market value.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.